Cancer immunotherapy: breaking the barriers to harvest the crop

被引：107

作者：

Pardoll, D ^{[1
]}

Allison, J

机构：

[1] Johns Hopkins Univ, Sch Med, Sidney Kimmel Canc Ctr, Baltimore, MD 21218 USA

[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

来源：

NATURE MEDICINE | 2004年 / 10卷 / 09期

基金：

美国国家卫生研究院;

关键词：

D O I：

10.1038/nm0904-887

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Successful translation of modern molecular immunology into effective cancer immunotherapy is threatened by regulatory barriers and challenges to the development of novel agents and combinatorial strategies through effective public-private partnerships. For its promise to be fully realized, both the National Cancer Institute and Food and Drug Administration must take active steps to help academic investigators and companies jointly navigate the pathways from laboratory to clinic.

引用

页码：887 / 892

页数：6

共 20 条

[11] Spinning molecular immunology into successful immunotherapy [J].

Pardoll, DM .

NATURE REVIEWS IMMUNOLOGY, 2002, 2 (04) :227-238

[12] Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma [J].

Phan, GQ ;

Yang, JC ;

Sherry, RM ;

Hwu, P ;

Topalian, SL ;

Schwartzentruber, DJ ;

Restifo, NP ;

Haworth, LR ;

Seipp, CA ;

Freezer, LJ ;

Morton, KE ;

Mavroukakis, SA ;

Duray, PH ;

Steinberg, SM ;

Allison, JP ;

Davis, TA ;

Rosenberg, SA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (14) :8372-8377

[13] Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. [J].

Slamon, DJ ;

Leyland-Jones, B ;

Shak, S ;

Fuchs, H ;

Paton, V ;

Bajamonde, A ;

Fleming, T ;

Eiermann, W ;

Wolter, J ;

Pegram, M ;

Baselga, J ;

Norton, L .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (11) :783-792

[14] Dangers of the amyloid-β vaccination [J].

Smith, MA ;

Joseph, JA ;

Atwood, CS ;

Perry, G .

ACTA NEUROPATHOLOGICA, 2002, 104 (01) :110-110

[15]

Stolberg Sheryl Gay, 1999, N Y Times Mag, P136

[16] Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25+ regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses [J].

Sutmuller, RPM ;

van Duivenvoorde, LM ;

van Elsas, A ;

Schumacher, TNM ;

Wildenberg, ME ;

Allison, JP ;

Toes, REM ;

Offringa, R ;

Melief, CJM .

JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (06) :823-832

[17] A personal history of the CAMPATH-1H antibody [J].

Waldmann, H .

MEDICAL ONCOLOGY, 2002, 19 (Suppl 2) :S3-S9

[18] Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer [J].

Willett, CG ;

Boucher, Y ;

di Tomaso, E ;

Duda, DG ;

Munn, LL ;

Tong, RT ;

Chung, DC ;

Sahani, DV ;

Kalva, SP ;

Kozin, SV ;

Mino, M ;

Cohen, KS ;

Scadden, DT ;

Hartford, AC ;

Fischman, AJ ;

Clark, JW ;

Ryan, DP ;

Zhu, AX ;

Blaszkowsky, LS ;

Chen, HX ;

Shellito, PC ;

Lauwers, GY ;

Jain, RK .

NATURE MEDICINE, 2004, 10 (02) :145-147

[19] HUMANIZED ANTIBODIES [J].

WINTER, G ;

HARRIS, WJ .

TRENDS IN PHARMACOLOGICAL SCIENCES, 1993, 14 (05) :139-143

[20] Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma:: In vivo persistence, migration, and antitumor effect of transferred T cells [J].

Yee, C ;

Thompson, JA ;

Byrd, D ;

Riddell, SR ;

Roche, P ;

Celis, E ;

Greenberg, PD .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (25) :16168-16173

← 1 2 →